Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Common Equity (2021 - 2025)

Coeptis Therapeutics Holdings has reported Common Equity over the past 5 years, most recently at $13.6 million for Q4 2025.

  • Quarterly results put Common Equity at $13.6 million for Q4 2025, up 300.99% from a year ago — trailing twelve months through Dec 2025 was $13.6 million (up 300.99% YoY), and the annual figure for FY2025 was $13.6 million, up 300.99%.
  • Common Equity for Q4 2025 was $13.6 million at Coeptis Therapeutics Holdings, up from $10.9 million in the prior quarter.
  • Over the last five years, Common Equity for COEPW hit a ceiling of $13.6 million in Q4 2025 and a floor of -$9.7 million in Q2 2021.
  • Median Common Equity over the past 5 years was $2.2 million (2022), compared with a mean of $2.3 million.
  • Biggest five-year swings in Common Equity: crashed 234.76% in 2024 and later surged 2383.47% in 2025.
  • Coeptis Therapeutics Holdings' Common Equity stood at $2.4 million in 2021, then surged by 89.45% to $4.5 million in 2022, then crashed by 81.72% to $813963.0 in 2023, then skyrocketed by 315.51% to $3.4 million in 2024, then surged by 300.99% to $13.6 million in 2025.
  • The last three reported values for Common Equity were $13.6 million (Q4 2025), $10.9 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.